Merck's Gardasil milestone reads as science - but WorkN'Play's Corporate Intelligence App reveals an operating model built to compound.

Two headlines from AstraZeneca landed within weeks of each other this summer: a licensing deal for Zegfrovy and a tumour-agnostic EU approval for Enhertu.

Pharmaceutical giants are strategically evolving, investing in innovation, talent, and infrastructure to drive global healthcare forward.